IRIS Accounts Production v26.1.10.61 08063657 director 1.4.25 31.3.26 31.3.26 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh080636572025-03-31080636572026-03-31080636572025-04-012026-03-31080636572024-03-31080636572024-04-012025-03-31080636572025-03-3108063657ns15:EnglandWales2025-04-012026-03-3108063657ns14:PoundSterling2025-04-012026-03-3108063657ns10:Director12025-04-012026-03-3108063657ns10:PrivateLimitedCompanyLtd2025-04-012026-03-3108063657ns10:SmallEntities2025-04-012026-03-3108063657ns10:AuditExempt-NoAccountantsReport2025-04-012026-03-3108063657ns10:SmallCompaniesRegimeForDirectorsReport2025-04-012026-03-3108063657ns10:SmallCompaniesRegimeForAccounts2025-04-012026-03-3108063657ns10:FullAccounts2025-04-012026-03-3108063657ns10:CompanySecretary12025-04-012026-03-3108063657ns10:RegisteredOffice2025-04-012026-03-3108063657ns5:CurrentFinancialInstruments2026-03-3108063657ns5:CurrentFinancialInstruments2025-03-3108063657ns5:ShareCapital2026-03-3108063657ns5:ShareCapital2025-03-3108063657ns5:RetainedEarningsAccumulatedLosses2026-03-3108063657ns5:RetainedEarningsAccumulatedLosses2025-03-3108063657ns5:FurnitureFittings2025-04-012026-03-3108063657ns5:MotorVehicles2025-04-012026-03-3108063657ns5:ComputerEquipment2025-04-012026-03-3108063657ns5:FurnitureFittings2025-03-3108063657ns5:MotorVehicles2025-03-3108063657ns5:ComputerEquipment2025-03-3108063657ns5:FurnitureFittings2026-03-3108063657ns5:MotorVehicles2026-03-3108063657ns5:ComputerEquipment2026-03-3108063657ns5:FurnitureFittings2025-03-3108063657ns5:MotorVehicles2025-03-3108063657ns5:ComputerEquipment2025-03-3108063657ns5:WithinOneYearns5:CurrentFinancialInstruments2026-03-3108063657ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3108063657ns5:DeferredTaxation2025-03-3108063657ns5:DeferredTaxation2025-04-012026-03-3108063657ns5:DeferredTaxation2026-03-31
REGISTERED NUMBER: 08063657 (England and Wales)















FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2026

FOR

HEALTHPHARM YORKSHIRE LIMITED

HEALTHPHARM YORKSHIRE LIMITED (REGISTERED NUMBER: 08063657)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


HEALTHPHARM YORKSHIRE LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2026







DIRECTOR: M Qamar





SECRETARY:





REGISTERED OFFICE: 24 Church Lane
Brighouse
West Yorkshire
HD6 1AS





REGISTERED NUMBER: 08063657 (England and Wales)





ACCOUNTANTS: Southbrook Accountants Limited
14 Southbrook Terrace
Bradford
West Yorkshire
BD7 1AD

HEALTHPHARM YORKSHIRE LIMITED (REGISTERED NUMBER: 08063657)

BALANCE SHEET
31 MARCH 2026

2026 2025
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 42,225 35,071

CURRENT ASSETS
Stocks 31,528 25,532
Debtors 5 886,564 709,070
Cash at bank and in hand 249,726 50,691
1,167,818 785,293
CREDITORS
Amounts falling due within one year 6 666,313 391,801
NET CURRENT ASSETS 501,505 393,492
TOTAL ASSETS LESS CURRENT
LIABILITIES

543,730

428,563

PROVISIONS FOR LIABILITIES 7 8,023 6,664
NET ASSETS 535,707 421,899

CAPITAL AND RESERVES
Called up share capital 120 120
Retained earnings 535,587 421,779
SHAREHOLDERS' FUNDS 535,707 421,899

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2026 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 18 June 2026 and were signed by:



M Qamar - Director


HEALTHPHARM YORKSHIRE LIMITED (REGISTERED NUMBER: 08063657)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026

1. STATUTORY INFORMATION

Healthpharm Yorkshire Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 20% on reducing balance
Motor vehicles - 20% on reducing balance
Computer equipment - 33% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 18 (2025 - 18 ) .

HEALTHPHARM YORKSHIRE LIMITED (REGISTERED NUMBER: 08063657)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2026

4. TANGIBLE FIXED ASSETS
Fixtures
and Motor Computer
fittings vehicles equipment Totals
£    £    £    £   
COST
At 1 April 2025 119,943 14,000 - 133,943
Additions 4,583 6,685 777 12,045
At 31 March 2026 124,526 20,685 777 145,988
DEPRECIATION
At 1 April 2025 96,489 2,383 - 98,872
Charge for year 2,804 1,830 257 4,891
At 31 March 2026 99,293 4,213 257 103,763
NET BOOK VALUE
At 31 March 2026 25,233 16,472 520 42,225
At 31 March 2025 23,454 11,617 - 35,071

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2026 2025
£    £   
Trade debtors 223,003 173,252
Other debtors 663,561 535,818
886,564 709,070

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2026 2025
£    £   
Trade creditors 299,268 207,795
Taxation and social security 50,372 24,925
Other creditors 316,673 159,081
666,313 391,801

7. PROVISIONS FOR LIABILITIES
2026 2025
£    £   
Deferred tax 8,023 6,664

Deferred
tax
£   
Balance at 1 April 2025 6,664
Provided during year 1,359
Balance at 31 March 2026 8,023

HEALTHPHARM YORKSHIRE LIMITED (REGISTERED NUMBER: 08063657)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2026

8. RELATED PARTY DISCLOSURES

During the year the company entered into the following related party transactions: -

QPharm Ltd - balance owed by/(owed to) was £297,913

In the previous period, a loan of £200,000 was provided by Healthpharm Yorkshire Ltd to QPharm Ltd. This has increased by £74,910 in this period.

9. ULTIMATE CONTROLLING PARTY

The ultimate controlling party is M Qamar.